Machine learning for comprehensive forecasting of Alzheimer's Disease progression.
Saved in:
| Title: | Machine learning for comprehensive forecasting of Alzheimer's Disease progression. |
|---|---|
| Authors: | Fisher CK; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA. drckf@unlearn.ai., Smith AM; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA., Walsh JR; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA. |
| Corporate Authors: | Coalition Against Major Diseases, Abbott, Alliance for Aging Research, Alzheimer’s Association, Alzheimer’s Foundation of America, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Critical Path Institute, CHDI Foundation, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Forest Research Institute, Genentech, Inc., GlaxoSmithKline, Johnson & Johnson, National Health Council, Novartis Pharmaceuticals Corporation, Parkinson’s Action Network, Parkinson’s Disease Foundation, Pfizer, Inc., sanofi-aventis. Collaborating Organizations: Clinical Data Interchange Standards Consortium (CDISC), Ephibian, Metrum Institute. |
| Source: | Scientific reports [Sci Rep] 2019 Sep 20; Vol. 9 (1), pp. 13622. Date of Electronic Publication: 2019 Sep 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
